These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19374981)

  • 61. Molecular detection of alpha-glucosidase inhibitor-producing actinomycetes.
    Hyun CG; Kim SY; Hur JH; Seo MJ; Suh JW; Kim SO
    J Microbiol; 2005 Jun; 43(3):313-8. PubMed ID: 15995652
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Synthesis, function, and evolutionary origin of secondary metabolites produced by micro-organisms].
    Santana C; Segura D; Sánchez S
    Rev Latinoam Microbiol; 1994; 36(2):139-58. PubMed ID: 7973181
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Actinomycetes: still a source of novel antibiotics.
    Genilloud O
    Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bioactivity-HiTES Unveils Cryptic Antibiotics Encoded in Actinomycete Bacteria.
    Moon K; Xu F; Zhang C; Seyedsayamdost MR
    ACS Chem Biol; 2019 Apr; 14(4):767-774. PubMed ID: 30830740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules.
    Okada BK; Seyedsayamdost MR
    FEMS Microbiol Rev; 2017 Jan; 41(1):19-33. PubMed ID: 27576366
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ecology and genomics of Actinobacteria: new concepts for natural product discovery.
    van Bergeijk DA; Terlouw BR; Medema MH; van Wezel GP
    Nat Rev Microbiol; 2020 Oct; 18(10):546-558. PubMed ID: 32483324
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The genus Nonomuraea: A review of a rare actinomycete taxon for novel metabolites.
    Sungthong R; Nakaew N
    J Basic Microbiol; 2015 May; 55(5):554-65. PubMed ID: 24633812
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.
    Olano C; Méndez C; Salas JA
    Nat Prod Rep; 2009 May; 26(5):628-60. PubMed ID: 19387499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria.
    Hoshino S; Onaka H; Abe I
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):363-374. PubMed ID: 30488365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Actinobacteria: the good, the bad, and the ugly.
    Miao V; Davies J
    Antonie Van Leeuwenhoek; 2010 Aug; 98(2):143-50. PubMed ID: 20390355
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Advances of genome and secondary metabolism in Streptomyces].
    Wu XC; Miao KP; Qian KX
    Yi Chuan Xue Bao; 2005 Nov; 32(11):1221-6. PubMed ID: 16318289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endophytic actinobacteria: Diversity, secondary metabolism and mechanisms to unsilence biosynthetic gene clusters.
    Dinesh R; Srinivasan V; T E S; Anandaraj M; Srambikkal H
    Crit Rev Microbiol; 2017 Sep; 43(5):546-566. PubMed ID: 28358596
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biotechnological potential of actinomycetes in the 21st century: a brief review.
    de Souza Rodrigues R; de Souza AQL; Feitoza MDO; Alves TCL; Barbosa AN; da Silva Santiago SRS; de Souza ADL
    Antonie Van Leeuwenhoek; 2024 May; 117(1):82. PubMed ID: 38789815
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Actinomycetes from mangrove and their secondary metabolites].
    Hong K
    Wei Sheng Wu Xue Bao; 2013 Nov; 53(11):1131-41. PubMed ID: 24617253
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Biosynthesis of benzoisochromanequinones antibiotics from streptomycetes--a review].
    Wang W; Wang H; Li A
    Wei Sheng Wu Xue Bao; 2012 May; 52(5):541-9. PubMed ID: 22803338
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
    Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
    Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era.
    van der Heul HU; Bilyk BL; McDowall KJ; Seipke RF; van Wezel GP
    Nat Prod Rep; 2018 Jun; 35(6):575-604. PubMed ID: 29721572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chapter 2. From microbial products to novel drugs that target a multitude of disease indications.
    Marinelli F
    Methods Enzymol; 2009; 458():29-58. PubMed ID: 19374978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Construction of a natural product library containing secondary metabolites produced by actinomycetes.
    Takagi M; Shin-Ya K
    J Antibiot (Tokyo); 2012 Sep; 65(9):443-7. PubMed ID: 22739538
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
    Krause J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.